Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Deferred Taxes (2016 - 2018)

Apyx Medical (APYX) has disclosed Deferred Taxes for 7 consecutive years, with $736000.0 as the latest value for Q4 2018.

  • For the quarter ending Q4 2018, Deferred Taxes rose 275.51% year-over-year to $736000.0, compared with a TTM value of $932000.0 through Dec 2019, up 5.67%, and an annual FY2018 reading of $368000.0, up 87.76% over the prior year.
  • Deferred Taxes was $736000.0 for Q4 2018 at Apyx Medical, up from $196000.0 in the prior quarter.
  • Across five years, Deferred Taxes topped out at $5.9 million in Q4 2014 and bottomed at -$1.3 million in Q3 2014.
  • Average Deferred Taxes over 4 years is $605375.0, with a median of $10000.0 recorded in 2014.
  • Peak annual rise in Deferred Taxes hit 1192.01% in 2014, while the deepest fall reached 109.74% in 2014.
  • Year by year, Deferred Taxes stood at $5.9 million in 2014, then crashed by 100.85% to -$50000.0 in 2016, then skyrocketed by 492.0% to $196000.0 in 2017, then skyrocketed by 275.51% to $736000.0 in 2018.
  • Business Quant data shows Deferred Taxes for APYX at $736000.0 in Q4 2018, $196000.0 in Q4 2017, and -$50000.0 in Q4 2016.